Phenotypic differentiation of GBM to astrocytoma is associated with reduced secretion of pro-inflammatory cytokines such as IL-6 and IL-8 as well as decreased expression of proteolytic enzymes including MMPs and urokinase-type plasminogen activator (uPA). Here, PLAU is linked to astrocytoma (excluding glioblastoma).